Trombetti Andrea, Pennisi Pietra, Rizzoli René
Service des maladies osseuses (Centre collaborateur de l'OMS pour la prévention de l'ostéoporose), département de réhabilitation et gériatrie, hôpitaux universitaires de Genève, 1211 Genève 14, Suisse.
Rev Prat. 2004 Dec 15;54(19):2132-7.
Osteoporosis and fractures are the frequent consequences of corticosteroid therapy. Cancellous bone is primarily affected with a decrease of bone formation and an increase of bone resorption. Prevention of corticosteroid-induced osteoporosis is based upon general measures such as calcium and vitamin D supplementation, adequate protein intake, regular physical exercise, and upon specific therapies like those used in primary osteoporosis. Biphosphonates, which are potent bone resorption inhibitors, have been shown to increase bone mineral density and to decrease vertebral fracture rate. Therefore, they appear to be a first choice in the prevention of corticosteroid-induced osteoporosis.
骨质疏松症和骨折是皮质类固醇治疗常见的后果。松质骨受到主要影响,骨形成减少而骨吸收增加。预防皮质类固醇诱发的骨质疏松症基于一般措施,如补充钙和维生素D、充足的蛋白质摄入、定期体育锻炼,以及基于原发性骨质疏松症所用的特定疗法。双膦酸盐是有效的骨吸收抑制剂,已被证明可增加骨矿物质密度并降低椎体骨折率。因此,它们似乎是预防皮质类固醇诱发骨质疏松症的首选。